Global Ioversol Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope of Ioversol
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Ioversol Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Ioversol 34% Injectable Solution (Optiray 160)
- 1.3.3 Ioversol 51% Injectable Solution (Optiray 240)
- 1.3.4 Ioversol 64% Injectable Solution (Optiray 300)
- 1.3.5 Ioversol 68% Injectable Solution (Optiray 320)
- 1.3.6 Ioversol 74% Injectable Solution (Optiray 350)
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Ioversol Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 X-ray
- 1.4.3 CT Scan
- 1.4.4 Brain Disorders
- 1.4.5 Blood Vessel Disorders
- 1.4.6 Heart Disorders
- 1.4.7 Others
- 1.5 Global Ioversol Market Size & Forecast
- 1.5.1 Global Ioversol Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Ioversol Sales Quantity (2019-2030)
- 1.5.3 Global Ioversol Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Liebel-Flarsheim Company LLC
- 2.1.1 Liebel-Flarsheim Company LLC Details
- 2.1.2 Liebel-Flarsheim Company LLC Major Business
- 2.1.3 Liebel-Flarsheim Company LLC Ioversol Product and Services
- 2.1.4 Liebel-Flarsheim Company LLC Ioversol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Liebel-Flarsheim Company LLC Recent Developments/Updates
- 2.2 Guerbet
- 2.2.1 Guerbet Details
- 2.2.2 Guerbet Major Business
- 2.2.3 Guerbet Ioversol Product and Services
- 2.2.4 Guerbet Ioversol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Guerbet Recent Developments/Updates
- 2.3 Jiangsu Hengrui Medicine Co
- 2.3.1 Jiangsu Hengrui Medicine Co Details
- 2.3.2 Jiangsu Hengrui Medicine Co Major Business
- 2.3.3 Jiangsu Hengrui Medicine Co Ioversol Product and Services
- 2.3.4 Jiangsu Hengrui Medicine Co Ioversol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Jiangsu Hengrui Medicine Co Recent Developments/Updates
- 2.4 Mallinckrodt Pharmaceuticals
- 2.4.1 Mallinckrodt Pharmaceuticals Details
- 2.4.2 Mallinckrodt Pharmaceuticals Major Business
- 2.4.3 Mallinckrodt Pharmaceuticals Ioversol Product and Services
- 2.4.4 Mallinckrodt Pharmaceuticals Ioversol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
- 2.5 Ultraject
- 2.5.1 Ultraject Details
- 2.5.2 Ultraject Major Business
- 2.5.3 Ultraject Ioversol Product and Services
- 2.5.4 Ultraject Ioversol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Ultraject Recent Developments/Updates
- 2.6 China Resources Pharmaceutical (Shanghai) Co
- 2.6.1 China Resources Pharmaceutical (Shanghai) Co Details
- 2.6.2 China Resources Pharmaceutical (Shanghai) Co Major Business
- 2.6.3 China Resources Pharmaceutical (Shanghai) Co Ioversol Product and Services
- 2.6.4 China Resources Pharmaceutical (Shanghai) Co Ioversol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 China Resources Pharmaceutical (Shanghai) Co Recent Developments/Updates
- 2.7 HB Ocean
- 2.7.1 HB Ocean Details
- 2.7.2 HB Ocean Major Business
- 2.7.3 HB Ocean Ioversol Product and Services
- 2.7.4 HB Ocean Ioversol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 HB Ocean Recent Developments/Updates
- 2.8 Novalek Pharmaceuticals Pvt. Ltd
- 2.8.1 Novalek Pharmaceuticals Pvt. Ltd Details
- 2.8.2 Novalek Pharmaceuticals Pvt. Ltd Major Business
- 2.8.3 Novalek Pharmaceuticals Pvt. Ltd Ioversol Product and Services
- 2.8.4 Novalek Pharmaceuticals Pvt. Ltd Ioversol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Novalek Pharmaceuticals Pvt. Ltd Recent Developments/Updates
- 2.9 Stellence Pharmscience Pvt. Ltd
- 2.9.1 Stellence Pharmscience Pvt. Ltd Details
- 2.9.2 Stellence Pharmscience Pvt. Ltd Major Business
- 2.9.3 Stellence Pharmscience Pvt. Ltd Ioversol Product and Services
- 2.9.4 Stellence Pharmscience Pvt. Ltd Ioversol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Stellence Pharmscience Pvt. Ltd Recent Developments/Updates
- 2.10 A.S. Joshi & Company
- 2.10.1 A.S. Joshi & Company Details
- 2.10.2 A.S. Joshi & Company Major Business
- 2.10.3 A.S. Joshi & Company Ioversol Product and Services
- 2.10.4 A.S. Joshi & Company Ioversol Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 A.S. Joshi & Company Recent Developments/Updates
3 Competitive Environment: Ioversol by Manufacturer
- 3.1 Global Ioversol Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Ioversol Revenue by Manufacturer (2019-2024)
- 3.3 Global Ioversol Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Ioversol by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Ioversol Manufacturer Market Share in 2023
- 3.4.2 Top 6 Ioversol Manufacturer Market Share in 2023
- 3.5 Ioversol Market: Overall Company Footprint Analysis
- 3.5.1 Ioversol Market: Region Footprint
- 3.5.2 Ioversol Market: Company Product Type Footprint
- 3.5.3 Ioversol Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Ioversol Market Size by Region
- 4.1.1 Global Ioversol Sales Quantity by Region (2019-2030)
- 4.1.2 Global Ioversol Consumption Value by Region (2019-2030)
- 4.1.3 Global Ioversol Average Price by Region (2019-2030)
- 4.2 North America Ioversol Consumption Value (2019-2030)
- 4.3 Europe Ioversol Consumption Value (2019-2030)
- 4.4 Asia-Pacific Ioversol Consumption Value (2019-2030)
- 4.5 South America Ioversol Consumption Value (2019-2030)
- 4.6 Middle East and Africa Ioversol Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Ioversol Sales Quantity by Type (2019-2030)
- 5.2 Global Ioversol Consumption Value by Type (2019-2030)
- 5.3 Global Ioversol Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Ioversol Sales Quantity by Application (2019-2030)
- 6.2 Global Ioversol Consumption Value by Application (2019-2030)
- 6.3 Global Ioversol Average Price by Application (2019-2030)
7 North America
- 7.1 North America Ioversol Sales Quantity by Type (2019-2030)
- 7.2 North America Ioversol Sales Quantity by Application (2019-2030)
- 7.3 North America Ioversol Market Size by Country
- 7.3.1 North America Ioversol Sales Quantity by Country (2019-2030)
- 7.3.2 North America Ioversol Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Ioversol Sales Quantity by Type (2019-2030)
- 8.2 Europe Ioversol Sales Quantity by Application (2019-2030)
- 8.3 Europe Ioversol Market Size by Country
- 8.3.1 Europe Ioversol Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Ioversol Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Ioversol Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Ioversol Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Ioversol Market Size by Region
- 9.3.1 Asia-Pacific Ioversol Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Ioversol Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Ioversol Sales Quantity by Type (2019-2030)
- 10.2 South America Ioversol Sales Quantity by Application (2019-2030)
- 10.3 South America Ioversol Market Size by Country
- 10.3.1 South America Ioversol Sales Quantity by Country (2019-2030)
- 10.3.2 South America Ioversol Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Ioversol Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Ioversol Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Ioversol Market Size by Country
- 11.3.1 Middle East & Africa Ioversol Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Ioversol Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Ioversol Market Drivers
- 12.2 Ioversol Market Restraints
- 12.3 Ioversol Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Ioversol and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Ioversol
- 13.3 Ioversol Production Process
- 13.4 Ioversol Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Ioversol Typical Distributors
- 14.3 Ioversol Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Ioversol market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Ioversol is an organoiodine compound, which contains one or more carbon-iodine bonds. It is a radiopaque contrast agent that absorbs X-rays. It allows blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (X-ray) examination. This unique property of ioversol has led to increased application such as in ultrasound scattering and magnetic resonance imaging. It helps to diagnose disorders of the heart, brain, and blood vessels.
Rise in number of accidents and increase in prevalence of bone-related diseases & kidney problems are the key drivers of the global ioversol market. In addition, growth in geriatric population has led to increased orthopedic disorders and cardiovascular disorders, resulting in the development of the X-ray industry, which in turn fuels the market growth. However, overdose of ioversol might lead allergic reaction; breathing problem; swelling of the face, lips, tongue, or throat; and dehydration & dry skin, which restrains the market growth. Increase in spending on healthcare and advancements in X-ray, CT scan, and other radiological & diagnostic examinations are anticipated to provide new opportunities for the market players.
The Global Info Research report includes an overview of the development of the Ioversol industry chain, the market status of X-ray (Ioversol 34% Injectable Solution (Optiray 160), Ioversol 51% Injectable Solution (Optiray 240)), CT Scan (Ioversol 34% Injectable Solution (Optiray 160), Ioversol 51% Injectable Solution (Optiray 240)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Ioversol.
Regionally, the report analyzes the Ioversol markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Ioversol market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Ioversol market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Ioversol industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (MT), revenue generated, and market share of different by Type (e.g., Ioversol 34% Injectable Solution (Optiray 160), Ioversol 51% Injectable Solution (Optiray 240)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Ioversol market.
Regional Analysis: The report involves examining the Ioversol market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Ioversol market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Ioversol:
Company Analysis: Report covers individual Ioversol manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Ioversol This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (X-ray, CT Scan).
Technology Analysis: Report covers specific technologies relevant to Ioversol. It assesses the current state, advancements, and potential future developments in Ioversol areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Ioversol market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Ioversol market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Ioversol 34% Injectable Solution (Optiray 160)
Ioversol 51% Injectable Solution (Optiray 240)
Ioversol 64% Injectable Solution (Optiray 300)
Ioversol 68% Injectable Solution (Optiray 320)
Ioversol 74% Injectable Solution (Optiray 350)
Market segment by Application
X-ray
CT Scan
Brain Disorders
Blood Vessel Disorders
Heart Disorders
Others
Major players covered
Liebel-Flarsheim Company LLC
Guerbet
Jiangsu Hengrui Medicine Co
Mallinckrodt Pharmaceuticals
Ultraject
China Resources Pharmaceutical (Shanghai) Co
HB Ocean
Novalek Pharmaceuticals Pvt. Ltd
Stellence Pharmscience Pvt. Ltd
A.S. Joshi & Company
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ioversol product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ioversol, with price, sales, revenue and global market share of Ioversol from 2019 to 2024.
Chapter 3, the Ioversol competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ioversol breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Ioversol market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ioversol.
Chapter 14 and 15, to describe Ioversol sales channel, distributors, customers, research findings and conclusion.